Your browser doesn't support javascript.
loading
Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study-authors' response.
Nagu, Tumaini J; Aboud, Said; Matee, Mecky I; Maeurer, Markus J; Fawzi, Wafaie W; Mugusi, Ferdinand.
Affiliation
  • Nagu TJ; Division of Therapeutic Immunology, Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, Sweden.
  • Aboud S; Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Matee MI; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.
  • Maeurer MJ; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.
  • Fawzi WW; Division of Therapeutic Immunology, Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, Sweden.
  • Mugusi F; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
J Antimicrob Chemother ; 73(6): 1735, 2018 06 01.
Article in En | MEDLINE | ID: mdl-29635525
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Isoniazid Type of study: Observational_studies Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2018 Document type: Article Affiliation country: Sweden Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Isoniazid Type of study: Observational_studies Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2018 Document type: Article Affiliation country: Sweden Country of publication: United kingdom